CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CVRX is expected to report earnings to rise 4.86% to -52 cents per share on August 04
Q2'26
Est.
$-0.52
Q1'26
Beat
by $0.02
Q4'25
Missed
by $0.02
Q3'25
Beat
by $0.01
Q2'25
Missed
by $0.05
The last earnings report on May 11 showed earnings per share of -50 cents, beating the estimate of -51 cents. With 65.74K shares outstanding, the current market capitalization sits at 128.96M.